Fate Therapeutics Reports Third Quarter 2019 Financial Results and Highlights Operational Progress

Go back to Fate Therapeutics Reports Third Quarter 2019 Financial Results and Highlights Operational Progress
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.02 +0.05 (2.54%)
Previous Close $1.97    52 Week High $4.76 
Open $2.00    52 Week Low $1.46 
Day High $2.16    P/E N/A 
Day Low $1.93    EPS $-1.91 
Volume 3,153,374